All ailments

Multiple Sclerosis (MS)

Get updates
Last reviewed June 12, 2026 · AI-assisted, human-reviewed

Overview

Autoimmune demyelinating disease. Anti-inflammatory nutrients have been studied as adjuncts to standard care.

Multiple Sclerosis (MS) is a chronic autoimmune disease affecting the brain and spinal cord, the central nervous system. In MS, the immune system mistakenly attacks the myelin sheath, which is the protective covering of nerve fibers, leading to communication problems between the brain and the rest of the body. Symptoms, which vary widely, may include fatigue, numbness, muscle weakness, vision problems, and issues with coordination. MS typically affects young adults, with women being two to three times more likely to develop it than men, and people often seek help for managing symptoms and slowing disease progression.
View Community Discussion

When to seek urgent medical care

  • New or worsening visual disturbances (e.g., blurred vision, double vision, loss of vision)
  • Sudden onset of numbness or tingling in limbs or face
  • Acute muscle weakness or paralysis in one or more limbs
  • Significant and unexplained difficulties with balance or walking
  • Rapidly progressing cognitive changes (e.g., memory, concentration)
  • Severe, unremitting fatigue impacting daily activities
  • Bladder or bowel dysfunction that is new or worsening

Common symptoms

  • Fatigue
  • Numbness or tingling
  • Muscle weakness
  • Vision problems (e.g., blurred vision, double vision, optic neuritis)
  • Dizziness or vertigo
  • Balance and coordination problems
  • Pain
  • Bladder dysfunction
  • Cognitive changes (e.g., memory, attention)
  • Spasticity

Possible contributors

  • Genetic predisposition
  • Environmental factors (e.g., Epstein-Barr virus infection)
  • Vitamin D deficiency
  • Smoking
  • Obesity (especially in adolescence)
  • Geographic location (higher incidence further from the equator)

Labs to discuss with your clinician

  • Vitamin D levels (25-hydroxyvitamin D)
  • Complete Blood Count (CBC)
  • Comprehensive Metabolic Panel (CMP)
  • Thyroid Panel (TSH, Free T3, Free T4)
  • Inflammatory markers (e.g., CRP, ESR)
  • Vitamin B12 levels
  • Myelin Basic Protein (MBP) (in CSF for diagnostic context)
  • Oligoclonal bands (OCB) (in CSF for diagnostic context)

All Remedies

Ranked by community outcomes, then evidence grade, Health Voice mentions, and recency.

Remedies

#1Vitamin D3Evidence · Grade ASafety: caution80% helpful · 5 reportsView remedy

Why it may help Multiple Sclerosis (MS): Vitamin D3 (cholecalciferol) is studied for its potential role in modulating immune responses, particularly Th1 and Th17 cells, which are implicated in the pathogenesis of MS. It also appears to support myelin repair signaling and contributes to calcium homeostasis, both of which may be relevant in MS. These actions collectively suggest a potential influence on disease activity and progression.

Individuals with MS, like any population, should be mindful of potential hypercalcemia with excessive vitamin D3 intake. It is important to discuss vitamin D supplementation with a healthcare provider, especially if taking other medications or managing comorbidities, to avoid potential interactions or adverse effects.

#3Cannabis / CBDEvidence · Grade BSafety: watchView remedy

Cannabis and CBD interact with the body's endocannabinoid system, showing potential for managing conditions like pain and inflammation, though more research is needed.

Emerging Research

#1TurmericEvidence · Grade DSafety: caution80% helpful · 5 reportsView remedy

Why it may help Multiple Sclerosis (MS): Turmeric, particularly its active compound curcumin, has been studied for its anti-inflammatory and immunomodulatory properties. In the context of Multiple Sclerosis (MS), curcumin appears to modulate pathways such as NF-kB and COX-2, which are involved in inflammation and neurodegeneration characteristic of the condition. These actions suggest a potential role in ameliorating MS-related inflammatory processes.

Individuals with MS who are taking immunosuppressants or blood thinners should exercise caution due to potential interactions with turmeric. High doses may cause gastrointestinal upset. As MS treatment often involves multiple medications, professional medical advice is crucial to assess potential contraindications or interactions specific to an individual's regimen.

#2Lion's Mane MushroomEvidence · Grade DSafety: caution80% helpful · 5 reportsView remedy

Why it may help Multiple Sclerosis (MS): Lion's Mane mushroom is studied for its potential neuroprotective and nerve-regenerating properties. Its active compounds, hericenones and erinacines, appear to stimulate nerve growth factor (NGF) synthesis, which could potentially support myelin integrity and nerve cell health. This mechanism suggests a possible role in conditions affecting the nervous system, such as MS.

Individuals with autoimmune conditions like MS should consult a healthcare provider before using Lion's Mane, as effects on the immune system are not fully understood in this context. Although generally well-tolerated, rare allergic reactions are possible, which could be a concern for individuals with multiple sensitivities.

#3Methylated B-ComplexEvidence · Grade CSafety: caution60% helpful · 5 reportsView remedy

Why it may help Multiple Sclerosis (MS): Methylated B-vitamins, particularly B12 and folate, are observed to be crucial for myelin synthesis and repair, a process that is often impaired in MS. B6 plays a role in neurotransmitter production, which could potentially support neurological function. Deficiencies in certain B vitamins appear to present symptoms that can resemble aspects of MS, suggesting a potential area of support.

While generally considered safe, long-term intake of B6 exceeding 200mg/day may be associated with neuropathy, which could be a significant concern for individuals with MS. Individuals with MS should consult their healthcare provider before supplementing, especially if taking other medications that may interact with B vitamins.

#4Omega-3 Fish OilEvidence · Grade CSafety: caution60% helpful · 5 reportsView remedy

Why it may help Multiple Sclerosis (MS): Omega-3 fatty acids, specifically EPA and DHA, are precursors to specialized pro-resolving mediators like resolvins and protectins, which may help resolve inflammation. DHA is also a crucial structural component of neuronal membranes and myelin. Therefore, supplementation may support neural health and modulate immune responses in conditions like MS.

Individuals with MS who are on immunomodulatory medications or anticoagulants should discuss omega-3 supplementation with a healthcare provider due to potential interactions. High doses of fish oil may increase the risk of bleeding.

#5BiotinEvidence · Grade CSafety: watchView remedy

Biotin is a B vitamin essential for metabolic processes, often associated with maintaining healthy hair, skin, and nails.

#6ProbioticsEvidence · Grade DSafety: watchView remedy

Why it may help Multiple Sclerosis (MS): Modulates gut-brain immunity

Dietary Protocols

Ketogenic DietC

Small trials and pilot studies suggest ketogenic and modified Atkins diets may reduce fatigue, improve quality of life, and lower inflammatory markers in relapsing MS. Used as an adjunct, not a replacement for disease-modifying therapy.

Emphasize

Fatty fish (salmon, sardines, mackerel), Pasture-raised eggs, Avocado and olives

Avoid

Sugar and sweetened beverages, Grains and starches (bread, pasta, rice, cereal), Most fruit (except small portions of berries)

View protocol
Autoimmune Protocol (AIP)C

Used clinically as an aggressive anti-inflammatory elimination; evidence overlaps with Wahls-style and paleo trials showing reduced fatigue in MS.

Emphasize

Quality meat, poultry, and seafood (especially wild-caught fatty fish), Organ meats once or twice weekly, A wide variety of non-nightshade vegetables and leafy greens

Avoid

All grains and pseudo-grains, All legumes (including peanuts and soy), All dairy

View protocol
Anti-Inflammatory DietC

Lowering systemic inflammation is a plausible adjunct to disease-modifying therapy; aligns with Mediterranean-derived MS data.

Emphasize

Fatty fish 2–3x/week (salmon, sardines, mackerel, herring), Extra-virgin olive oil, Berries, cherries, and other deeply colored fruit

Avoid

Sugar-sweetened beverages and refined sugar, Ultra-processed snacks and ready meals, Industrial seed oils used at high heat (soybean, corn, sunflower, cottonseed)

View protocol
Vegan DietC

Small trials (e.g. Swank-style and McDougall plant-based diets) suggest reductions in fatigue and improved quality of life in MS.

Emphasize

Legumes (lentils, beans, peas, tofu, tempeh, edamame), Whole grains (oats, barley, quinoa, brown rice), Vegetables and fruit, with leafy greens daily

Avoid

Refined grains and sugar as the bulk of meals, Heavily processed vegan junk foods, Coconut and palm oils in excess

View protocol

Community outcomes

What people report for Multiple Sclerosis (MS)

Self-reported by community members · not medical advice.

What people report for this condition

Self-reported community outcomes. Not medical advice. Requires at least three reports per remedy to surface.

Total reports

25

Reported worked

72%

Mixed results

28%

Did not work

0%

Top reported helpful approaches

Most reported did not help

Not enough reports yet.

Most reported side effects

People Like Me insights

As more members share outcomes, RemedyAtlas will show which remedies helped people with similar conditions, symptoms, goals, and lab patterns.

Community discussion

Structured experience reports from people managing this condition. Not medical advice.

You can share without an account — we'll send a one-time code to verify your email. Or sign in.

Loading posts…

Community Discussions

What people say about Multiple Sclerosis (MS)

Search on Reddit →

Lifestyle foundations

  • Regular, tailored physical activity to maintain mobility and muscle strength
  • Fatigue management strategies, including planned rest periods
  • Stress reduction techniques (e.g., mindfulness, meditation, yoga)
  • Balanced nutrition, emphasizing whole foods and anti-inflammatory diets
  • Adequate sleep hygiene for restorative rest
  • Avoiding smoking and excessive alcohol consumption
  • Maintaining a healthy weight

International evidence & guidelines

How global health authorities view Multiple Sclerosis (MS).

    Health Voice Perspectives

    Independent of evidence grade

    Approved mentions from health educators, physicians, and researchers across podcasts, videos, and articles. Educational context only — does not influence the scientific evidence rating above.

    • TW
      Terry Wahls· MD, University of Iowa; Clinical Professor of Medicine

      Dr. Terry Wahls and Garrett Salpeter propose that adopting an "athlete mindset" can significantly aid individuals with Multiple Sclerosis (MS) in their recovery journey. This approach is discussed as a method to facilitate brain rewiring and improve quality of life, potentially leading to substantial functional gains. The core idea emphasizes the power of mindset in neuroplasticity for MS patients.

      "The mindset of "If you have a body, you’re an athlete" is helping MS patients rewire their brains and reclaim their lives. • This mindset can lead to significant functional improvements, such as going from foot drop to dancing again."
      YouTubeView source ·6/12/2026
    • TW
      Terry Wahls· MD, University of Iowa; Clinical Professor of Medicine

      Dr. Terry Wahls and Garrett Salpeter discuss how electrical stimulation and task-specific training, particularly using the Neubie device and NeuFit methodology, can leverage neuroplasticity in individuals with Multiple Sclerosis. They explore its potential to help regain lost function, reduce fatigue, improve mobility, and enhance cognition. The discussion highlights the difference between assistive devices and nervous system re-education, emphasizing personalized therapy for recovery.

      "Electrical stimulation and task-specific training can tap into neuroplasticity to help individuals with MS. • The NeuFit methodology, including the Neubie device, can assist in regaining lost function, reducing fatigue, and improving mobility in MS patients. • Neuroplasticity can be harnessed by MS patients to improve their condition. • Electrical stimulation can reduce foot drop, improve balance, and restore mobility. • Cognition and energy can be enhanced via the vagus nerve and parasympathetic activation."
      YouTubeView source ·6/12/2026

    Evidence ecosystem

    Indexed studies for Multiple Sclerosis (MS), grouped by source type and quality.

    Filter by source type

    Clinical Guidelines(20)

    Recommendations from medical societies (NICE, AHA, ADA, ACG, Endocrine Society…).

    High Quality
    • ACR Appropriateness Criteria® Demyelinating Diseases.

      Expert Panel on Neurologic Imaging, Kalnins A, Lewis LM, Soderlund KA, Austin MJ, Chu S · Journal of the American College of Radiology : JACR · 2026

      Demyelinating diseases of the central nervous system represent a diverse spectrum of inflammatory disorders affecting myelin sheaths, including multiple sclerosis (MS), neuromyelitis optica spectrum disorders (NMOSD), and myelin oligodendrocyte glycoprotein antibody-associated disorders (MOGAD). MRI is the cornerstone imaging modality, providing superior sensitivity over CT for detecting demyelinating lesions in the brain and spinal cord. Advanced MRI techniques such as diffusion tensor imaging, magnetization transfer imaging, and AI applications enhance diagnostic accuracy. The 2024 McDonald criteria integrate new imaging features such as central vein sign and paramagnetic rim lesions, improving MS diagnosis with 94% accuracy at 3T MRI. Gadolinium enhancement patterns distinguish active inflammatory lesions from chronic plaques, with specific morphologic characteristics differentiating MS from NMOSD and MOGAD. Spinal cord MRI reveals characteristic lesion patterns: short peripheral le

      Clinical GuidelinePubMed (Practice Guideline)Very High Quality
    • French guidelines for the diagnosis and management of MOG antibody-associated disease.

      Giorgi L, Marignier R, Pique J, Maurey H, Papeix C, Ciron J · Revue neurologique · 2025

      MOG antibody-associated disease (MOGAD) is a new entity within the spectrum of autoimmune inflammatory diseases of the central nervous system. It is distinct from multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD). Although they share certain clinical characteristics, these 3 diseases differ in terms of their pathophysiology, disease course and response to treatment. MOGAD is a rare disease affecting both adults and children, with a higher frequency in the latter. The clinical presentation of MOGAD varies depending on age: in children under the age of 10, presentations of acute disseminated encephalomyelitis (ADEM) are frequently described, whereas in children over the age of 10 and in adults, unilateral or bilateral optic neuritis or acute myelitis is more often observed. Other, rarer presentations have also been reported, including encephalitic presentations with seizures. Radiologic findings can sometimes help guide the diagnosis: extensive anterior optic ner

      Clinical GuidelinePubMed (Practice Guideline)Very High Quality
    • Multiple Sclerosis Disease-Modifying Treatment Algorithms: 2025 Positioning of the Portuguese Multiple Sclerosis Study Group.

      Capela C, Santos E, Palavra F, Guimarães J, Cerqueira J, Vale J · Acta medica portuguesa · 2025

      Multiple sclerosis (MS) is a chronic autoimmune-mediated neurodegenerative disease characterized by inflammation, demyelination, and axonal/neuronal damage in the central nervous system. In Portugal, the prevalence of MS is approximately 64.4 per 100 000 individuals. It is typically diagnosed in young adults aged 30 to 40, with a higher incidence in women, although it can also affect children/adolescents and the elderly. Recent advances in MS treatment include the development and approval of several new disease-modifying therapies (DMTs) such as ocrelizumab, cladribine, siponimod, and others, thus expanding options for relapsing-remitting MS (RRMS). However, the options for progressive forms of MS remain limited. In Portugal, MS management strategies, guided by the 2015 recommendations of the Directorate-General of Health and the Portuguese medicines agency, need updating to incorporate recent scientific evidence and clinical expertise. The aim of this manuscript is to highlight gaps i

      Clinical GuidelinePubMed (Practice Guideline)Very High Quality

    Clinical Trial Registries(33)

    Registered ongoing or completed trials (ClinicalTrials.gov).

    Moderate Quality
    • Art for MS - Effects of a 10 Week Multimodal Dance and Art Intervention Program on Fatigue, Fatigability, and Their Related Factors - A Controlled Pilot-trial

      n=17 · NCT03938558 · COMPLETED · COMPLETED

      This study is a controlled pilot study with 17 participants with Multiple Sclerosis (MS). The primary goal of this study is to objectively examine the effects of a multimodal dance intervention on walking-related performance fatigability. The secondary aim is to investigate the effects of a multimodal dance intervention on other MS symptoms related to fatigue and fatigability. The following research questions will be addressed: 1. Does a multimodal dance intervention have positive effects on walking-related fatigability? 2. Does a multimodal dance intervention have positive effects on other MS symptoms related to fatigue and fatigability?

      Clinical TrialClinicalTrials.govModerate Quality
    • Strengthening Mental Abilities With Relational Training (SMART) in Multiple Sclerosis (MS): A Feasibility Trial

      n=60 · NCT04975685 · UNKNOWN · UNKNOWN

      Background: Multiple Sclerosis (MS) is a chronic condition of the central nervous system; around 1 in 600 people in the United Kingdom have MS. Many people with MS (70%) have cognitive difficulties, which they experience as distressing and disabling, and there is currently a lack of treatment options to improve these difficulties. SMART (Strengthening Mental Abilities with Relational Training) - a theory-based online cognitive training programme, which has been shown to improve general cognitive abilities - has not been tested with people who have MS. Aims: To conduct a feasibility study to inform development of a definitive trial of SMART for improving cognitive functioning in people with MS. The investigators will assess: 1. Acceptability to participants of the intervention, delivery format, inclusion/exclusion criteria, baseline and outcome measures, randomisation protocol, and study procedures 2. The framework for a cost-effectiveness analysis alongside a definitive trial 3. Participant recruitment and retention rates 4. Sample-size needed for fully powered trial 5. Signal of efficacy Plan: To address Aims 1-5, the investigators will recruit 60 adults with MS who are experiencing cognitive difficulties, identified from MS clinics. Participants will complete baseline assessments of their cognitive abilities and answer questionnaires about their cognitive difficulties, personal priorities, mood, fatigue, self-efficacy, quality of life, and healthcare services used. Assessments will be administered by a researcher, face-to-face or remotely. Participants will be randomly allocated to one of three arms (20 per group): Group 1: Receives SMART intervention online - plus usual care (MS Nurse support). SMART intervention involves completing a series of logic problems, which are designed to train skills that scaffold complex cognition. Group 2: Receives usual care alone. Group 3: Receives a 'control' intervention online - plus usual care. Baseline measures will be re-administered at three- and six-months post-randomisation. Researchers and patient-partners (people with personal experience of MS, who will act as co-researchers) will also interview 30 participants about their experience of the study and treatment. All qualitative data will be transcribed and thematically analysed in terms of a priori feasibility aims. Quantitative data will enable sample-size calculation for a definitive study and determine signal of efficacy.

      Clinical TrialClinicalTrials.govModerate Quality
    • Safety and Efficacy Study of OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity (NDO) in Non-Catheterizing Patients With Multiple Sclerosis (MS)

      n=144 · NCT01600716 · COMPLETED · COMPLETED

      This study will evaluate the safety and efficacy of OnabotulinumtoxinA (BOTOX®) for the treatment of urinary incontinence due to NDO in non-catheterizing patients with MS.

      Clinical TrialClinicalTrials.govModerate Quality

    Evidence Summaries(1)

    Curated cross-source summaries (TRIP Database and similar).

    High Quality
    • TRIP Database search for Multiple Sclerosis

      TRIP Database

      TRIP Database is a clinical search engine designed to allow users to quickly and easily find high-quality research evidence to support their practice, including numerous resources on Multiple Sclerosis.

      Evidence SummaryTRIP DatabaseHigh Quality

    Working alongside conventional care

    Conventional medical care for MS often involves diagnosis through neurological examination, MRI scans, and sometimes lumbar puncture. Treatment typically focuses on managing relapses, slowing disease progression with disease-modifying therapies (DMTs), and alleviating symptoms through pharmacotherapy and rehabilitation.

    Related conditions

    Optic neuritisTransverse myelitisNeuromyelitis optica spectrum disorder (NMOSD)Sjögren's syndromeLupusRheumatoid arthritis

    Latest News

    Latest news on Multiple Sclerosis (MS)

    More on Google News →

    Health Videos

    Health videos on Multiple Sclerosis (MS)

    More on YouTube

    The information provided about Multiple Sclerosis (MS) is for educational purposes only and should not be considered medical advice. MS is a complex condition requiring individualized diagnosis and management by qualified healthcare professionals. Always consult with your doctor or a specialist for

    Found something that helped your multiple sclerosis (ms)?

    Help others see what actually works.